Histologic spectrum of nonalcoholic fatty liver disease in morbidly obese adolescents
2
Xanthakos S et al (2006) Histologic spectrum of nonalcoholic fatty liver disease in morbidly obese adolescents. Clin Gastroenterol Hepatol 4(2):226-232
Laparoscopic Roux-en-Y versus mini-gastric bypass for the treatment of morbid obesity: A prospective randomized controlled clinical trial
1
Lee WJ et al (2005) Laparoscopic Roux-en-Y versus mini-gastric bypass for the treatment of morbid obesity: a prospective randomized controlled clinical trial. Ann Surg 242(1):20-28
One-year outcomes of Roux-en-Y gastric bypass for morbidly obese adolescents: A multicenter study from the Pediatric Bariatric Study Group
1. discussion 137-143
Lawson ML et al (2006) One-year outcomes of Roux-en-Y gastric bypass for morbidly obese adolescents: a multicenter study from the Pediatric Bariatric Study Group. J Pediatr Surg 41(1):137-143 discussion 137-143
Comparison of changes in lipid profile after bilio-intestinal bypass and gastric banding in patients with morbid obesity
3
Corradini SG et al (2005) Comparison of changes in lipid profile after bilio-intestinal bypass and gastric banding in patients with morbid obesity. Obes Surg 15(3):367-377
Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects
4
Faraj M et al (2003) Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects. J Clin Endocrinol Metab 88(4):1594-1602
Ghrelin and adipose tissue regulatory peptides: Effect of gastric bypass surgery in obese humans
7
Holdstock C et al (2003) Ghrelin and adipose tissue regulatory peptides: effect of gastric bypass surgery in obese humans. J Clin Endocrinol Metab 88(7):3177-3183